Detalles de la búsqueda
1.
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database.
Diabetes Ther
; 14(2): 401-413, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36596946
2.
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis.
Diabetes Ther
; 13(1): 57-73, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784005
3.
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis.
Diabetes Ther
; 12(4): 1073-1097, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650085
4.
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis.
Diabetes Ther
; 12(4): 1159-1174, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33751403
5.
Rationale and methodology for a European pooled analysis of postmarketing interventional and observational studies of insulin glargine 300 U/mL in diabetes: protocol of REALI project.
BMJ Open
; 10(4): e033659, 2020 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32350009
6.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Clin Breast Cancer
; 17(1): 48-54.e3, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693116
Resultados
1 -
6
de 6
1
Próxima >
>>